Ho Ching-Huang, Dippel Maxwell A, McQuade Meghan S, Mishra Arpit, Pribitzer Stephan, Nguyen LeAnn P, Hardy Samantha, Chandok Harshpreet, Chardon Florence, McDiarmid Troy A, DeBerg Hannah A, Buckner Jane H, Shendure Jay, de Boer Carl G, Guo Michael H, Tewhey Ryan, Ray John P
bioRxiv. 2024 Oct 11:2024.10.07.617092. doi: 10.1101/2024.10.07.617092.
Genetic variants associated with autoimmune diseases are highly enriched within putative -regulatory regions of CD4 T cells, suggesting that they alter disease risk via changes in gene regulation. However, very few genetic variants have been shown to affect T cell gene expression or function. We tested >18,000 autoimmune disease-associated variants for allele-specific expression using massively parallel reporter assays in primary human CD4 T cells. The 545 expression-modulating variants (emVars) identified greatly enrich for likely causal variants. We provide evidence that many emVars are mediated by common upstream regulatory conduits, and that putative target genes of primary T cell emVars are highly enriched within a lymphocyte activation network. Using bulk and single-cell CRISPR-interference screens, we confirm that emVar-containing T cell -regulatory elements modulate both known and novel target genes that regulate T cell proliferation, providing plausible mechanisms by which these variants alter autoimmune disease risk.
与自身免疫性疾病相关的基因变异在CD4 T细胞假定的调控区域内高度富集,这表明它们通过基因调控的变化改变疾病风险。然而,很少有基因变异被证明会影响T细胞基因表达或功能。我们在原代人CD4 T细胞中使用大规模平行报告基因检测法,对超过18000个与自身免疫性疾病相关的变异进行了等位基因特异性表达测试。鉴定出的545个表达调节变异(emVars)极大地富集了可能的因果变异。我们提供的证据表明,许多emVars是由常见的上游调控途径介导的,并且原代T细胞emVars的假定靶基因在淋巴细胞激活网络中高度富集。通过批量和单细胞CRISPR干扰筛选,我们证实含有emVar的T细胞调控元件调节已知和新的调控T细胞增殖的靶基因,为这些变异改变自身免疫性疾病风险提供了合理的机制。